Ralph J. Lamson v. United States

110 Fed. Cl. 691, 2013 U.S. Claims LEXIS 195, 2013 WL 1120500
CourtUnited States Court of Federal Claims
DecidedMarch 15, 2013
Docket11-377C
StatusPublished

This text of 110 Fed. Cl. 691 (Ralph J. Lamson v. United States) is published on Counsel Stack Legal Research, covering United States Court of Federal Claims primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Ralph J. Lamson v. United States, 110 Fed. Cl. 691, 2013 U.S. Claims LEXIS 195, 2013 WL 1120500 (uscfc 2013).

Opinion

Claim construction; “virtual reality immersion therapy” method patent

OPINION

FIRESTONE, Judge.

This is a patent infringement case brought under 28 U.S.C. § 1498 1 (2006). Plaintiff *694 Ralph J. Lamson (“plaintiff’) alleges that defendant the United States (“the government”) has infringed United States Patent Number 6,425,764 (“ ’764 patent”), which was filed by plaintiff in 1997 and entitled “Virtual Reality Immersion Therapy for Treating Psychological, Psychiatric, Medical, Educational and Self-Help Problems.” 2 Now before the court are the parties’ briefs regarding the construction of seven claim terms used in the ’764 patent.

1. BACKGROUND

The ’764 patent lays claim to certain virtual reality immersion therapy (“VRIT”) methods for treating psychological, psychiatric, and medical conditions. Plaintiff alleges that at least as early as 2004, the United States Department of Defense, Department of Veterans Affairs, and Department of Health and Human Services have used, directly and through procurement and grant contracts, the VRIT methods described in the '764 patent without authorization by plaintiff, most prominently for treating posLtraumatie stress disorder.

A. The ’764 patent.

In general terms, the ’764 patent describes a method for treating psychological, psychiatric or medical conditions by exposing patients to an interactive virtual reality environment and providing sensors that monitor and evaluate a patient’s responses the virtual reality environment. The Abstract of the ’764 patent describes the VRIT methods as follows:

A method of treating a psychological, psychiatric, or medical condition by choosing a psychological strategy for treating the condition, encoding electronic instructions for a virtual reality environment in such a way that the interactive virtual reality environment implements the psychological strategy, loading electronic instructions into a virtual reality technology unit equipped with a display for displaying the virtual reality environment and with a patient input device for receiving responses to the environment from the patient, and instructing the human patient how and when to use the virtual reality technology unit to interact with the environment. The interactive environment contains instructions for a scoring procedure for quantitatively analyzing the medical condition of the patient, and/or counseling instructions or self-help instructions. The environment can be used in conjunction with a physical parameter measuring device connected to the virtual reality technology unit. The process is comprehensive and takes place during immersion in fully interactive three-dimensional virtual reality environments utilizing computer generated graphics, images imported from photographs, and video for sensory stimulation. Immersion is achieved with goggles, a head-mounted-display, or other form of visual stimulation, such as surround projection screens or monitors or devices that permit the user to have a virtual experience. It includes the use of voice, music, and sound and other forms of physiological stimulation and feedback. Body sensors and devices such as a hand-held grip permit the user to interact with objects and navigate within the virtual environment.

’764 patent at 1 (reference numbers to figures omitted).

The ’764 patent is comprised of four independent claims (Claims 1, 19, 23, and 26) and twenty-seven dependent claims that define the scope of the invented methods. 3 Plaintiff alleges that the government has made unauthorized use of the invention described in Claims 1, 2-4, 7, 9-13, 18-21, 23, and 25-31, *695 inclusive, of the ’764 patent. See Revised Joint Claim Construction Statement, EOF No. 32.

The four independent claims of the ’764 patent — Claims 1, 19, 23, and 26 — describe several methods of treating or evaluating a “psychological, psychiatric, or medical condition in a human patient” using virtual reality immersion therapy. Independent Claim 1 includes all but one of the disputed claim terms (disputed claim terms are underlined the first time they appear):

1. A method for treating a psychological, psychiatric, or medical condition in a human patient, comprising:
(a) choosing a psychological strategy for treating said psychological, psychiatric, or medical condition;
(b) providing an interactive virtual reality environment;
(1) said interactive virtual reality environment comprising a technology unit arranged to display to said human patient a plurality of virtual reality environments;
(2) said technology unit having an input for receiving feedback responses to said interactive virtual reality environment from said human patient;
(3) said technology unit arranged to change said virtual reality environment in response to said feedback responses from said human patient;
(c) selecting said virtual reality environment to correspond to said psychological strategy;
(d) encoding electronic instructions for said interactive virtual reality environment;
(e) loading said electronic [instructions] into said virtual reality technology unit; and
(f) instructing said human patient how and when to use said virtual reality technology unit so as to experience said interactive virtual reality environment and how and when to provide feedback responses to said technology unit for changing said virtual reality environment so as to treat said psychological, psychiatric, or medical condition.

Independent Claim 19 describes a similar treatment method, and contains the remaining disputed claim term (underlined):

19. A method of treating a psychological, psychiatric, or medical condition in a human patient comprising:
(a) providing a plurality of sets of instructions or steps for treating said psychological, psychiatric, or medical condition;
(b) choosing one of said sets of instructions or steps which is appropriate for treating said psychological, psychiatric, or medical condition of said human patient;
(e) providing a virtual reality technology unit arranged to provide an interactive virtual reality environment;
(1) said virtual reality [] technology unit being equipped with a display means;
(2) said virtual reality technology unit also being equipped with an input means for receiving responses to said interactive virtual reality environment from said human patient;

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Baran v. Medical Device Technologies, Inc.
616 F.3d 1309 (Federal Circuit, 2010)
Agilent Technologies, Inc. v. Affymetrix, Inc.
567 F.3d 1366 (Federal Circuit, 2009)
Epistar Corp. v. International Trade Commission
566 F.3d 1321 (Federal Circuit, 2009)
Paragon Solutions, LLC v. Timex Corp.
566 F.3d 1075 (Federal Circuit, 2009)
Abbott Laboratories v. Sandoz, Inc.
566 F.3d 1282 (Federal Circuit, 2009)
Helmsderfer v. Bobrick Washroom Equipment, Inc.
527 F.3d 1379 (Federal Circuit, 2008)
Chamberlain Group, Inc. v. Lear Corp.
516 F.3d 1331 (Federal Circuit, 2008)
Z4 Technologies, Inc. v. Microsoft Corp.
507 F.3d 1340 (Federal Circuit, 2007)
Pfizer, Inc. v. Teva Pharmaceuticals Usa, Inc.
429 F.3d 1364 (Federal Circuit, 2005)
August Technology Corp. v. Camtek, Ltd.
655 F.3d 1278 (Federal Circuit, 2011)
Vitronics Corporation v. Conceptronic, Inc.
90 F.3d 1576 (Federal Circuit, 1996)
Medtronic Inc. v. Boston Scientific Corp.
695 F.3d 1266 (Federal Circuit, 2012)
In Re Abbott Diabetes Care Inc.
696 F.3d 1142 (Federal Circuit, 2012)
Securitypoint Holdings, Inc. v. United States
111 Fed. Cl. 1 (Federal Claims, 2013)
Boston Scientific Corp. v. MICRUS CORP.
556 F. Supp. 2d 1045 (N.D. California, 2008)

Cite This Page — Counsel Stack

Bluebook (online)
110 Fed. Cl. 691, 2013 U.S. Claims LEXIS 195, 2013 WL 1120500, Counsel Stack Legal Research, https://law.counselstack.com/opinion/ralph-j-lamson-v-united-states-uscfc-2013.